By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Bluejay Diagnostics, Inc.

Bluejay Diagnostics, Inc. (BJDX)

NASDAQ Currency in USD
$496.00
-$7.80
-1.55%
Last Update: 19 Jul 2026, 03:56
$222.73m
Market Cap
-35.43
P/E Ratio (TTM)
Forward Dividend Yield
$324.15-$666.05
52 Week Range

BJDX Stock Price Chart

Explore Bluejay Diagnostics, Inc. interactive price chart. Choose custom timeframes to analyze BJDX price movements and trends.

BJDX Company Profile

Discover essential business fundamentals and corporate details for Bluejay Diagnostics, Inc. (BJDX) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Devices

IPO Date

10 Nov 2021

Employees

6.00

CEO

Indranil Dey

Description

Bluejay Diagnostics, Inc. functions as a company specializing in medical diagnostic solutions. A key offering is their Symphony platform, an advanced technological system. This platform is composed of the Symphony analyzer, which skillfully orchestrates the processing of whole blood, the isolation of biomarkers, and the preparation of immunoassays using non-contact centrifugal force. It also includes the Symphony Cartridge, which comes pre-loaded with essential reagents and components. The company additionally provides the ALLEREYE diagnostic test, a convenient, on-site device for quickly identifying allergic conjunctivitis. Bluejay Diagnostics is also progressing with the development of Symphony IL-6 tests, intended for monitoring disease advancement in critical care environments. Furthermore, they are actively creating additional diagnostic tests for their Symphony platform, such as those aimed at detecting myocardial infarction (heart attack) and congestive heart failure. Bluejay Diagnostics, Inc. was founded in 2015 and is headquartered in Acton, Massachusetts.

BJDX Financial Timeline

Browse a chronological timeline of Bluejay Diagnostics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 19 Aug 2026

EPS estimate is -$3.52k.

Earnings released on 13 May 2026

EPS came in at -$1.95 .

Earnings released on 6 Mar 2026

EPS came in at -$2.37 .

Stock split effective on 29 Jan 2026

Shares were split 1 : 4 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 7 Nov 2025

EPS came in at -$4.04 .

Earnings released on 7 Aug 2025

EPS came in at -$1.41 .

Earnings released on 13 May 2025

EPS came in at -$3.37 .

Earnings released on 31 Mar 2025

EPS came in at -$112.37 surpassing the estimated -$144.00 by +21.97%, while revenue for the quarter reached $216.09k .

Stock split effective on 18 Nov 2024

Shares were split 1 : 50 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 7 Nov 2024

EPS came in at -$8.00 surpassing the estimated -$144.00 by +94.44%.

Earnings released on 14 Aug 2024

EPS came in at -$256.00 falling short of the estimated -$144.00 by -77.78%.

Stock split effective on 20 Jun 2024

Shares were split 1 : 8 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 15 May 2024

EPS came in at -$396.00 surpassing the estimated -$1.15k by +65.63%.

Earnings released on 28 Mar 2024

EPS came in at -$712.00 falling short of the estimated -$272.00 by -161.76%, while revenue for the quarter reached $1.45m .

Earnings released on 9 Nov 2023

EPS came in at -$832.00 falling short of the estimated -$328.00 by -153.66%.

Earnings released on 14 Aug 2023

EPS came in at -$1.10k falling short of the estimated -$600.00 by -83.33%.

Stock split effective on 24 Jul 2023

Shares were split 1 : 20 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 10 May 2023

EPS came in at -$960.00 falling short of the estimated -$480.00 by -100.00%.

Earnings released on 20 Mar 2023

EPS came in at -$960.00 falling short of the estimated $320.00 by -400.00%.

Earnings released on 9 Nov 2022

EPS came in at -$1.12k falling short of the estimated -$640.00 by -75.00%.

Earnings released on 26 Jul 2022

EPS came in at -$800.00 falling short of the estimated -$640.00 by -25.00%, while revenue for the quarter reached $249.04k .

Earnings released on 20 Apr 2022

EPS came in at -$800.00 surpassing the estimated -$880.00 by +9.09%.

Earnings released on 10 Mar 2022

EPS came in at -$720.00 .

Earnings released on 16 Dec 2021

EPS came in at -$39.16 .

BJDX Stock Performance

Access detailed BJDX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run